Skip to Content
You are currently on the new version of our website. Access the old version .
BiomedicinesBiomedicines
  • Review
  • Open Access

15 April 2022

11 Pages

Advanced Imaging in Cardiac Amyloidosis

,
,
,
and
1
Kardiologie Solothurner Spitäler, 4500 Solothurn, Switzerland
2
Radiologie Bürgerspital Solothurn, 4500 Solothurn, Switzerland
*
Author to whom correspondence should be addressed.

Abstract

This review serves as a synopsis of multimodality imaging in cardiac amyloidosis (CA), which is a disease characterized by deposition of misfolded protein fragments in the heart. It emphasizes and summarizes the diagnostic possibilities and their prognostic values. In general, echocardiography is the first diagnostic tool in patients with an identified systemic disease or unclear left ventricular hypertrophy. Several echocardiographic parameters will raise suspicion and lead to further testing. Cardiac magnetic resonance and scintigraphy with bone avid radiotracers are crucial for diagnosis of CA and even enable a distinction between different subtypes. The subject is illuminated with established guidelines and innovative recent publications to further improve early diagnosis of cardiac amyloidosis in light of current treatment options.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.